Lung Cancer and Mediastinal Tumors

Paul Frost Clementsen; Peter Vilmann; Lars Konge; Jouke Annema

doi:10.1002/9781118555651.ch33

Lung Cancer and Mediastinal Tumors

Paul Frost Clementsen, Peter Vilmann, Lars Konge, Jouke Annema

Institut for Klinisk Medicin

1 Citationer (Scopus)

Abstract

Many studies including randomized trials have demonstrated a major impact of transesophageal ultrasound-guided fine-needle aspiration (EUS-FNA) on management of patients with lung cancer and patients with undiagnosed lesions in the lungs and the mediastinum. Implementation of endosonography in lung cancer staging protocols reduces surgical staging by at least half and prevents futile thoracotomies. It is expected that the combination of EUS-FNA and endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) will replace surgical staging in the vast majority of lung cancer patients in a near future. Furthermore, a growing number of studies have demonstrated that a variety of other mediastinal lesions can be diagnosed by endosonography, for example, tuberculosis, lymphoma, sarcoidosis, and metastases from primary tumors such as renal cancer, breast cancer, and pancreatic cancer. This edition first published 2013

Originalsprog	Engelsk
Titel	Gastrointestinal endoscopy in the cancer patient
Redaktører	John C Deutsch, Matthew R. Banks
Antal sider	10
Udgivelsessted	Chichester, West Sussex
Forlag	Wiley-Blackwell
Publikationsdato	26 feb. 2013
Sider	345-354
Kapitel	33
ISBN (Trykt)	9780470672464
DOI	https://doi.org/10.1002/9781118555651.ch33
Status	Udgivet - 26 feb. 2013

FN’s Verdensmål

Dette resultat bidrager til følgende verdensmål

Adgang til dokumentet

10.1002/9781118555651.ch33

Citationsformater

@inbook{9697937f0028412eade749a11e264efe,

title = "Lung Cancer and Mediastinal Tumors",

abstract = "Many studies including randomized trials have demonstrated a major impact of transesophageal ultrasound-guided fine-needle aspiration (EUS-FNA) on management of patients with lung cancer and patients with undiagnosed lesions in the lungs and the mediastinum. Implementation of endosonography in lung cancer staging protocols reduces surgical staging by at least half and prevents futile thoracotomies. It is expected that the combination of EUS-FNA and endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) will replace surgical staging in the vast majority of lung cancer patients in a near future. Furthermore, a growing number of studies have demonstrated that a variety of other mediastinal lesions can be diagnosed by endosonography, for example, tuberculosis, lymphoma, sarcoidosis, and metastases from primary tumors such as renal cancer, breast cancer, and pancreatic cancer. This edition first published 2013",

author = "Clementsen, {Paul Frost} and Peter Vilmann and Lars Konge and Jouke Annema",

year = "2013",

month = feb,

day = "26",

doi = "10.1002/9781118555651.ch33",

language = "English",

isbn = "9780470672464 ",

pages = "345--354",

editor = "Deutsch, { John C} and Banks, {Matthew R.}",

booktitle = "Gastrointestinal endoscopy in the cancer patient",

publisher = "Wiley-Blackwell",

address = "United Kingdom",

}

TY - CHAP

T1 - Lung Cancer and Mediastinal Tumors

AU - Clementsen, Paul Frost

AU - Vilmann, Peter

AU - Konge, Lars

AU - Annema, Jouke

PY - 2013/2/26

Y1 - 2013/2/26

N2 - Many studies including randomized trials have demonstrated a major impact of transesophageal ultrasound-guided fine-needle aspiration (EUS-FNA) on management of patients with lung cancer and patients with undiagnosed lesions in the lungs and the mediastinum. Implementation of endosonography in lung cancer staging protocols reduces surgical staging by at least half and prevents futile thoracotomies. It is expected that the combination of EUS-FNA and endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) will replace surgical staging in the vast majority of lung cancer patients in a near future. Furthermore, a growing number of studies have demonstrated that a variety of other mediastinal lesions can be diagnosed by endosonography, for example, tuberculosis, lymphoma, sarcoidosis, and metastases from primary tumors such as renal cancer, breast cancer, and pancreatic cancer. This edition first published 2013

AB - Many studies including randomized trials have demonstrated a major impact of transesophageal ultrasound-guided fine-needle aspiration (EUS-FNA) on management of patients with lung cancer and patients with undiagnosed lesions in the lungs and the mediastinum. Implementation of endosonography in lung cancer staging protocols reduces surgical staging by at least half and prevents futile thoracotomies. It is expected that the combination of EUS-FNA and endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) will replace surgical staging in the vast majority of lung cancer patients in a near future. Furthermore, a growing number of studies have demonstrated that a variety of other mediastinal lesions can be diagnosed by endosonography, for example, tuberculosis, lymphoma, sarcoidosis, and metastases from primary tumors such as renal cancer, breast cancer, and pancreatic cancer. This edition first published 2013

U2 - 10.1002/9781118555651.ch33

DO - 10.1002/9781118555651.ch33

M3 - Book chapter

SN - 9780470672464

SP - 345

EP - 354

BT - Gastrointestinal endoscopy in the cancer patient

A2 - Deutsch, John C

A2 - Banks, Matthew R.

PB - Wiley-Blackwell

CY - Chichester, West Sussex

ER -

Lung Cancer and Mediastinal Tumors

Abstract

FN’s Verdensmål

Adgang til dokumentet

Fingeraftryk

Citationsformater